Intervention Protocol

Newer anticonvulsants in the treatment of anxiety disorders

  1. Jonathan C Ipser1,*,
  2. Dan J Stein2

Editorial Group: Cochrane Depression, Anxiety and Neurosis Group

Published Online: 18 OCT 2006

DOI: 10.1002/14651858.CD006241


How to Cite

Ipser JC, Stein DJ. Newer anticonvulsants in the treatment of anxiety disorders (Protocol). Cochrane Database of Systematic Reviews 2006, Issue 4. Art. No.: CD006241. DOI: 10.1002/14651858.CD006241.

Author Information

  1. 1

    University of Stellenbosch, MRC Research Unit for Anxiety and Stress Disorders, Western Cape, South Africa

  2. 2

    University of Cape Town, Department of Psychiatry and Mental Health, Cape Town, South Africa

*Jonathan C Ipser, MRC Research Unit for Anxiety and Stress Disorders, University of Stellenbosch, PO Box 19063, Tygerberg, Western Cape, 7505, South Africa. jonathan.ipser@uct.ac.za.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 18 OCT 2006

SEARCH

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

1) To use evidence from RCTs in providing an estimate of the overall effects of the newer anticonvulsants in improving treatment response and reducing symptom severity in the treatment of anxiety disorders.

2) To determine whether particular anticonvulsants are more effective and tolerable than others in the treatment of anxiety disorders.

3) To determine whether the particular anxiety disorder treated predicts the effectiveness of anticonvulsants in terms of efficacy and tolerability.

4) To identify which factors (clinical, methodological) predict response to pharmacotherapy.